FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2166930077> ?p ?o ?g. }

• W2166930077 endingPage "129" @default.
• W2166930077 startingPage "125" @default.
• W2166930077 abstract "<h3>Background:</h3> Trials and clinical observations have demonstrated the efficacy of mycophenolate mofetil (MMF) for SLE treatment. Long-term use of MMF is associated with adverse events, pregnancy risks, drug monitoring, and increased cost. Current management continues therapy indefinitely. Whether immunosuppression may be safely withdrawn or whether risks of withdrawal outweigh the benefits of continuation is unknown. <h3>Objectives:</h3> To compare rates of clinically significant disease reactivation (CSDR), major flares, and all flares in patients with quiescent SLE on stable MMF randomized to maintain or withdraw MMF. The goal is to provide guidance for clinicians and patients on the risks of MMF withdrawal. <h3>Methods:</h3> Adults with quiescent SLE (SELENA-SLEDAI without serologies <4) receiving MMF for ≥2 years for nephritis or ≥ 1 year for non-nephritis were randomized 1:1 to unblinded MMF (maintenance arm, MA) or to a 12-week taper off MMF (withdrawal arm, WA) and followed through 60 weeks. Subjects were on stable hydroxychloroquine; steroids limited to ≤ 10 mg. CSDR, defined as a SLEDAI flare requiring immunosuppression, BILAG flares and adverse events were assessed. Event rates and time to flare were compared using Kaplan-Meier. <h3>Results:</h3> 102 subjects were randomized (50 MA, 52 WA); 1 subject in each arm was ineligible and 10 terminated early (7 MA, 3 WA). Mean disease duration was 13 years; 76% had a history of nephritis; mean baseline SLEDAI was 2.2. 5 MA subjects (10%) had CSDR, compared to 9 WA (17%). Median time to CDSR was 38 weeks in both arms. BILAG A flares occurred in 1MA subject (pancreatitis) vs. 4 WA (cranial neuropathy, panniculitis, 2 nephritis). Kaplan-Meier curves overlapped for CDSR, BILAG A flares, and all SLEDAI flares (Figure). Based on these data, we are 86% confident that the increased risk of CDSR with MMF withdrawal is less than 15% over 60 weeks. AEs were similar between groups; infections occurred more commonly in MA (63 vs. 49). <h3>Conclusion:</h3> In this cohort of subjects with quiescent SLE on long term MMF serious flares occurred infrequently in subjects continuing or withdrawing MMF without differences in time to flare. MMF withdrawal may be considered in subjects with prolonged quiescent disease. <h3>Disclosure of Interests:</h3> Eliza Chakravarty: None declared, Tammy Utset: None declared, Diane L Kamen Consultant of: Consulted on SLE survey development for Lilly and consulted on SLE trial protocol development for EMD Serono in 2019, Gabriel Contreras Grant/research support from: Genentech, Merck, Consultant of: Genentech, Merck, William Joseph McCune: None declared, Kenneth C Kalunian: None declared, Cynthia Aranow: None declared, Megan Clowse Grant/research support from: GSK, Pfizer, Consultant of: UCB, Astra-Zeneca, Speakers bureau: UCB, Ellen Goldmuntz: None declared, Jessica Springer: None declared, Lynette Keyes-Elstein: None declared, Bill Barry: None declared, Ashley Pinckney: None declared, Judith James: None declared" @default.
• W2166930077 created "2016-06-24" @default.
• W2166930077 creator A5011398209 @default.
• W2166930077 creator A5015988282 @default.
• W2166930077 creator A5029123237 @default.
• W2166930077 creator A5040500651 @default.
• W2166930077 creator A5043750063 @default.
• W2166930077 creator A5065617566 @default.
• W2166930077 creator A5074888361 @default.
• W2166930077 creator A5079281059 @default.
• W2166930077 date "2010-11-25" @default.
• W2166930077 modified "2023-10-02" @default.
• W2166930077 title "YY1 expression predicts favourable outcome in follicular lymphoma" @default.
• W2166930077 cites W2006396189 @default.
• W2166930077 cites W2007027997 @default.
• W2166930077 cites W2047266923 @default.
• W2166930077 cites W2051298961 @default.
• W2166930077 cites W2054464598 @default.
• W2166930077 cites W2066162956 @default.
• W2166930077 cites W2107363136 @default.
• W2166930077 cites W2118577784 @default.
• W2166930077 cites W2123782380 @default.
• W2166930077 cites W2125323026 @default.
• W2166930077 cites W2171530407 @default.
• W2166930077 cites W2183972091 @default.
• W2166930077 cites W2883845660 @default.
• W2166930077 doi "https://doi.org/10.1136/jcp.2010.078188" @default.
• W2166930077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21109702" @default.
• W2166930077 hasPublicationYear "2010" @default.
• W2166930077 type Work @default.
• W2166930077 sameAs 2166930077 @default.
• W2166930077 citedByCount "28" @default.
• W2166930077 countsByYear W21669300772013 @default.
• W2166930077 countsByYear W21669300772014 @default.
• W2166930077 countsByYear W21669300772015 @default.
• W2166930077 countsByYear W21669300772016 @default.
• W2166930077 countsByYear W21669300772017 @default.
• W2166930077 countsByYear W21669300772018 @default.
• W2166930077 countsByYear W21669300772019 @default.
• W2166930077 countsByYear W21669300772020 @default.
• W2166930077 countsByYear W21669300772021 @default.
• W2166930077 countsByYear W21669300772022 @default.
• W2166930077 countsByYear W21669300772023 @default.
• W2166930077 crossrefType "journal-article" @default.
• W2166930077 hasAuthorship W2166930077A5011398209 @default.
• W2166930077 hasAuthorship W2166930077A5015988282 @default.
• W2166930077 hasAuthorship W2166930077A5029123237 @default.
• W2166930077 hasAuthorship W2166930077A5040500651 @default.
• W2166930077 hasAuthorship W2166930077A5043750063 @default.
• W2166930077 hasAuthorship W2166930077A5065617566 @default.
• W2166930077 hasAuthorship W2166930077A5074888361 @default.
• W2166930077 hasAuthorship W2166930077A5079281059 @default.
• W2166930077 hasConcept C126322002 @default.
• W2166930077 hasConcept C168563851 @default.
• W2166930077 hasConcept C197934379 @default.
• W2166930077 hasConcept C2779123688 @default.
• W2166930077 hasConcept C2779134260 @default.
• W2166930077 hasConcept C2779912601 @default.
• W2166930077 hasConcept C2780252810 @default.
• W2166930077 hasConcept C3008058167 @default.
• W2166930077 hasConcept C524204448 @default.
• W2166930077 hasConcept C71924100 @default.
• W2166930077 hasConceptScore W2166930077C126322002 @default.
• W2166930077 hasConceptScore W2166930077C168563851 @default.
• W2166930077 hasConceptScore W2166930077C197934379 @default.
• W2166930077 hasConceptScore W2166930077C2779123688 @default.
• W2166930077 hasConceptScore W2166930077C2779134260 @default.
• W2166930077 hasConceptScore W2166930077C2779912601 @default.
• W2166930077 hasConceptScore W2166930077C2780252810 @default.
• W2166930077 hasConceptScore W2166930077C3008058167 @default.
• W2166930077 hasConceptScore W2166930077C524204448 @default.
• W2166930077 hasConceptScore W2166930077C71924100 @default.
• W2166930077 hasIssue "2" @default.
• W2166930077 hasLocation W21669300771 @default.
• W2166930077 hasLocation W21669300772 @default.
• W2166930077 hasOpenAccess W2166930077 @default.
• W2166930077 hasPrimaryLocation W21669300771 @default.
• W2166930077 hasRelatedWork W1971572559 @default.
• W2166930077 hasRelatedWork W1985181188 @default.
• W2166930077 hasRelatedWork W2097213097 @default.
• W2166930077 hasRelatedWork W2129539804 @default.
• W2166930077 hasRelatedWork W2243536757 @default.
• W2166930077 hasRelatedWork W2754900871 @default.
• W2166930077 hasRelatedWork W3118245782 @default.
• W2166930077 hasRelatedWork W3193728860 @default.
• W2166930077 hasRelatedWork W4249342726 @default.
• W2166930077 hasRelatedWork W4256514411 @default.
• W2166930077 hasVolume "64" @default.
• W2166930077 isParatext "false" @default.
• W2166930077 isRetracted "false" @default.
• W2166930077 magId "2166930077" @default.
• W2166930077 workType "article" @default.